Therese M. Becker - Concepedia

Author

Therese M. Becker

Also Known As

Becker, Therese, Becker, Therese M., T Becker, T M Becker, T. Becker, T. M. Becker, T.M. Becker, Therese Becker, Therese M Becker, Therese M. Becker

141

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Westmead Hospital Westmead Institute Ingham Institute Western Sydney University

About

Therese M. Becker is an author at The University of Sydney specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1K
2	Cell Biology	16	17	820
3	Health Sciences	2	2	99
4	Engineering	1	1	64
5	Public Health	1	1	15

Therese M. Becker

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Clinical Cancer Research	2014	538
Vemurafenib Induces Senescence Features in Melanoma Cells Sebastian Haferkamp, Andreas Borst, Christian Adam, Journal of Investigative Dermatology Tumor BiologyMelanomaCellular SenescenceMedicineCell Biology	2013	110
Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Elizabeth A. Holland, S C Beaton, Therese M. Becker, PubMed	1995	102
Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS Chen Chen Jiang, Fritz Lai, Kwang Hong Tay, Cell Death and Disease	2010	99
Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition Kavitha Gowrishankar, Stephanie Snoyman, Gulietta M. Pupo, Journal of Investigative Dermatology	2012	88
Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors Sebastian Haferkamp, Lyndee L. Scurr, Therese M. Becker, Journal of Investigative Dermatology MedicineMelanomaCancer Cell BiologyCellular SenescenceCancer Biology	2009	85
Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma Matteo S. Carlino, Kavitha Gowrishankar, Catherine A.B. Saunders, Molecular Cancer Therapeutics Resistant MelanomaImmunologyTumor BiologyOncologyReceptor Tyrosine Kinase	2013	82
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence Sebastian Haferkamp, Sieu L. Tran, Therese M. Becker, Aging Tumour FormationCell DeathCell ProliferationTumor BiologyCell Regulation	2009	74
Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor Therese M. Becker, Sosman Boyd, Branka Mijatov, Oncogene Transcriptional RegulationSystems BiologySignal TransductionSignaling PathwayCell Regulation	2013	68
Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin Joseph W. Po, Aflah Roohullah, David T. Lynch, Journal of Circulating Biomarkers	2018	68

Page 1